American Association for the Study of Liver Diseases

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

1.113 documents for American Association for the Study of Liver Diseases

- Salix Pharmaceuticals Previews Data Slated for Presentation at 62nd Annual Meeting of the American Association for the Study of Liver Diseases.
RALEIGH, N.C. -- Salix Pharmaceuticals, Inc. (NASDAQ:SLXP) today announced that the 62nd Annual Meeting of the American Association for the Study of L...
- Business Wire
- November 04, 2011
- Interim Data for Merck's VICTRELISTM (boceprevir) in Prior Null Responder Patients with Chronic Hepatitis C Genotype 1 to be Presented at The American Association for the Study of Liver Diseases 2011 Annual Meeting.
New Phase I Data to be Presented on MK-5172, Merck's Investigational Once-Daily, Second-Generation Oral HCV NS3/4A Protease Inhibitor SAN FRANCISCO ...
- Business Wire
- November 05, 2011
- American Association for the Study of Liver Diseases Continues and Expands Educational Partnership with Clinical Care Options
RESTON, Va., Oct. 18 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative online, print, and live medical education for healthcare professionals, announced the expansion of its partnership with the American Association for the Study of Liver Diseases (AASLD). For the third year, CCO will serve as the official provider of online Conference Coverage of The Liver Meeting(R) held in Boston, Massachusetts, October 29 - November 2, 2010. Based on the past success of our joint educational programs, we are pleased to continue our collaboration with CCO to create exceptional and innovative online CME activities for healthcare providers treating hepatitis and other liver diseases," said Arun J. Sanyal, MD, 60th President of the AASLD. "We consistently...
- U.S. Newswire
- October 18, 2010

- Salix Pharmaceuticals Previews Data Slated for Presentation at 61st Annual Meeting of the American Association for the Study of Liver Diseases.
BOSTON -- Salix Pharmaceuticals, Inc. (NASDAQ:SLXP) today announced that the 61st Annual Meeting of the American Association for the Study of Liver Di...
- Business Wire
- October 30, 2010
- Salix Pharmaceuticals Reviews American Association for the Study of Liver Diseases Annual Meeting.
Data Demonstrate Protective Effect and Durability of Rifaximin for Maintenance of Remission of Hepatic Encephalopathy Data Demonstrate Rifaximin Sig...
- Business Wire
- November 02, 2009
- ISCO to Present Data on Progress of Human Parthenogenetic Stem Cell Differentiation into Functional Liver Cells at the Annual Meeting of the American Association for the Study of Liver Diseases.
OCEANSIDE, Calif. -- International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, will present data on its progress toward produci...
- Business Wire
- October 07, 2010
- Alnylam Scientists to Present New Data on RNAi Therapeutics at the 61st Annual Meeting of the American Association for the Study of Liver Diseases.
- Research Highlights Include Potential New Therapeutic Applications for RNAi Therapeutics in Liver Fibrosis - CAMBRIDGE, Mass. -- Alnylam Pharmaceu...
- Business Wire
- October 29, 2010
- Idera Pharmaceuticals Announces IMO-2125 Presentation at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).
CAMBRIDGE, Mass. -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that data related to IMO-2125, its novel immune modulator for the treat...
- Business Wire
- October 01, 2010
- ; Presented: Tuesday, November 8, 11:15 Am
SAN FRANCISCO, Nov. 8, 2011 /PRNewswire/ --- By examining multiple-cause death records, researchers from the Centers for Disease Control and Prevention have determined that deaths from viral hepatitis are insufficiently appreciated and by 2007 were exceeding reported deaths caused by HIV. Approximately 21.8 million records were included in the study, which was presented at the annual meeting of the American Association for the Study of Liver Diseases on Tuesday, November 8. Those records were examined for mention of hepatitis B or C and for HIV. For the period of 1999 to 2007, deaths associated with hepatitis B remained constant, HIV declined, and hepatitis C increased - significantly. Almost three-quarters of HCV-related deaths occurred in the 45-64 year-old age group. HIV was one of t...
- U.S. Newswire
- November 08, 2011
- American Association for the Study of Liver Diseases Enters Into Agreement with Clinical Care Options As Its Authorized Online Conference Coverage Provider for the Liver Meeting(R) 2008
To: NATIONAL EDITORS Contact: Vincent Keane of Clinical Care Options, +1-703-674- 3546, vkeane@clinicaloptions.com; or Gregory Bologna of the American Association for the Study of Liver Diseases, +1-703-299-9766, gbologna@aasld.org
- U.S. Newswire
- October 15, 2008